Imagine spending thousands of dollars on weight-loss medication—only to discover months later that it doesn't work for your ...

A less costly, but still effective use of continuous glucose monitors is being adopted by the local healthcare system ...

I am what many people would call a “crunchy mum” – someone who tends to favour natural, low-tox and environmentally conscious ...

A hormonal disorder affecting about 1 in 8 women worldwide has officially been renamed after years of concern that its old name pointed patients, doctors, and researchers in the wrong direction.

The Medical College of Georgia's Savannah campus utilizes partnership with St. Joseph's/Candler to provide hands-on learning for students.

A surprising new study suggests that completely eliminating sugar may backfire. Mice on a sucrose-free low-fat diet showed worse blood sugar control, increased inflammation, disrupted gut bacteria, ...

Sperm quality improved in men with obesity after a course of GLP-1 drugs. Credit: Steve Gschmeissner/SPL. The latest generation of obesity drugs might have another potential benef ...

Heart failure (HF) remains a pressing health concern, with rising prevalence globally. Subjectivity and ambiguity in the definition of HF and its antecedent stages have limited research, global ...

The Wegovy pill—a daily tablet taken by mouth when you wake up—was approved by the FDA in December 2025 and contains the same active ingredient (semaglutide) as the weekly injections you ...

Hoffmann-La Roche Limited (Roche Canada) is pleased to announce that it successfully completed negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) for Itovebi (inavolisib) on May 26, ...

Semaglutide may offer an added bone health benefit while helping manage type 2 diabetes and obesity, providing encouraging ...

Women taking GLP-1 receptor agonists, the class of drugs behind semaglutide and liraglutide, had 35.1 percent lower odds of ...